
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $396.3K | -- | -- | -$0.24 | -- |
07/17/2025 | Q2 | $2.5M | -- | -- | -$0.20 | -- |
04/30/2025 | Q1 | $369.1K | $1.1M | -$0.21 | -$0.24 | $0.02 |
03/13/2025 | Q4 | $820.9K | $1.3M | -$0.18 | -$0.21 | $0.03 |
10/24/2024 | Q3 | $8.4M | $29.5M | $0.06 | -$0.22 | $0.28 |
07/17/2024 | Q2 | $75.9M | $759.6K | -$0.25 | $0.27 | -$0.53 |
04/25/2024 | Q1 | $5.8M | -- | -$0.21 | -$0.13 | -$0.08 |
02/06/2024 | Q4 | $11.4M | $16.7M | -$0.06 | -$0.18 | $0.12 |
11/03/2023 | Q3 | -- | -- | -$0.20 | -$0.18 | -$0.03 |
08/04/2023 | Q2 | -- | -- | -$0.22 | -$0.24 | $0.02 |
04/28/2023 | Q1 | -- | -- | -$0.23 | -$0.24 | $0.01 |
03/16/2023 | Q4 | -- | -- | -$0.24 | -$0.25 | $0.01 |
10/28/2022 | Q3 | -- | -- | -$0.17 | -$0.22 | $0.05 |
07/28/2022 | Q2 | -- | -- | -$0.24 | -$0.23 | -$0.01 |
04/28/2022 | Q1 | -- | -- | -$0.25 | -$0.22 | -$0.03 |
03/22/2022 | Q4 | -- | -- | -$0.28 | -$0.28 | -$0.00 |
11/08/2021 | Q3 | -- | -- | -$0.24 | -$0.31 | $0.07 |
08/04/2021 | Q2 | -- | -- | -$0.29 | -- | -- |
04/28/2021 | Q1 | -- | -- | -$0.25 | -$0.22 | -$0.04 |
03/30/2021 | Q4 | -- | -- | -$0.30 | -- | -- |
11/13/2020 | Q3 | -- | -- | -$0.28 | -- | -- |
08/05/2020 | Q2 | -- | -- | -$0.23 | -- | -- |
05/04/2020 | Q1 | -- | -- | -$0.11 | -- | -- |
03/30/2020 | Q4 | -- | -- | -$0.28 | -- | -- |
11/13/2019 | Q3 | -- | -- | $0.25 | -- | -- |
08/14/2019 | Q2 | -- | -- | -$0.24 | -- | -- |
05/15/2019 | Q1 | -- | -- | $0.91 | -- | -- |
03/21/2019 | Q4 | -- | -- | -$0.21 | -- | -- |
11/13/2018 | Q3 | -- | -- | -$0.21 | -- | -- |
08/08/2018 | Q2 | -- | -- | -$0.19 | -- | -- |
05/02/2018 | Q1 | -- | -- | -$0.21 | -- | -- |
03/20/2018 | Q4 | -- | -- | $0.08 | -- | -- |
11/13/2017 | Q3 | -- | -- | -$0.16 | -- | -- |
08/09/2017 | Q2 | -- | -- | -$0.22 | -- | -- |
03/31/2017 | Q1 | -- | -- | -$0.17 | -- | -- |
03/17/2017 | Q4 | -- | -- | -$0.09 | -- | -- |
09/30/2016 | Q3 | -- | -- | -$0.18 | -- | -- |
06/30/2016 | Q2 | -- | -- | $0.24 | -- | -- |
03/31/2016 | Q1 | -- | -- | -$0.11 | -- | -- |
12/31/2015 | Q4 | -- | -- | -$0.10 | -- | -- |
09/30/2015 | Q3 | -- | -- | $0.38 | -- | -- |
AC Immune SA reported $1.1M worth of top line sales in its most recent quarter.
AC Immune SA announced earnings per share of -$0.21 which represents a beat of analyst forecast a -$0.24 per share.
AC Immune SA reported -- that represents -- per share over the last quarter.
AC Immune SA's earnings are forecast to decrease from -$0.58 per share to -$0.60 per share next year representing a decrease of -56.94%.
Currently, AC Immune SA has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on October 16, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.